ArticleJournal of experimental & clinical cancer research : CR2025

An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activities.

Lais C G F Palhares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.